Last reviewed · How we verify

Bleaching Agents

André Luis Faria e Silva · FDA-approved active Small molecule

Bleaching agents work by oxidizing or chemically altering pigmented molecules in skin to lighten hyperpigmented areas or remove discoloration.

Bleaching agents work by oxidizing or chemically altering pigmented molecules in skin to lighten hyperpigmented areas or remove discoloration. Used for Hyperpigmentation and melasma, Post-inflammatory hyperpigmentation, Age spots and solar lentigines.

At a glance

Generic nameBleaching Agents
SponsorAndré Luis Faria e Silva
Drug classTopical depigmenting agent
TargetTyrosinase (primary); melanin (direct oxidation)
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Bleaching agents typically contain active ingredients such as hydroquinone, kojic acid, or hydrogen peroxide that inhibit melanin synthesis or promote melanin degradation through oxidative processes. These agents are applied topically to reduce the appearance of dark spots, melasma, post-inflammatory hyperpigmentation, and other forms of skin discoloration by suppressing tyrosinase activity or directly bleaching existing pigment.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: